Beauty Farm Medical & Health Industry, Inc. (HK:2373)
:2373
Want to see HK:2373 full AI Analyst Report?
2373 Stock Chart & Stats
HK$26.36
HK$0.14(0.75%)
At close: 4:00 PM EST
HK$26.36
HK$0.14(0.75%)
Day’s Range― - ―
52-Week RangeHK$16.30 - HK$41.60
Previous CloseN/A
Volume52.00K
Average Volume (3M)539.77K
Market Cap
HK$4.60B
Enterprise ValueHK$4.36B
Total Cash (Recent Filing)HK$2.57B
Total Debt (Recent Filing)HK$1.29B
Price to Earnings (P/E)11.2
Beta0.43
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.97%
Share Statistics
EPS (TTM)1.38
Shares Outstanding251,593,720
10 Day Avg. Volume911,428
30 Day Avg. Volume539,766
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)5.54
Price to Sales (P/S)1.89
P/FCF Ratio6.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$31.31Price Target Upside18.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
EPS Forecast (FY)1.79
Revenue Forecast (FY)HK$3.99B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained top-line expansion, with a notable step-up in 2025, indicates durable market demand and successful capacity or service scaling. Strong revenue growth supports reinvestment, improves fixed-cost absorption and underpins multi-period cash flow projections for 2–6 months and beyond.
Improving MarginsMargin improvement shows rising profitability and likely operational leverage or pricing power. Higher net and gross margins enhance sustainable earnings generation, increase retained earnings and strengthen the firm’s ability to fund growth or service obligations over future reporting periods.
Cash GenerationImproving operating and free cash flow in 2025 reflects effective cash conversion and working-capital management. Reliable cash generation supports capital expenditures, debt servicing and shareholder distributions, improving financial flexibility over the medium term despite other uncertainties.
Bears Say
Rising LeverageA sharp rise in leverage materially increases financial risk and reduces balance-sheet flexibility. Higher debt raises interest and refinancing exposure, constrains strategic optionality and makes operational setbacks more damaging to cash flow and credit metrics over the coming months.
Cash Flow ConsistencyMixed FCF signals and reported zero coverage metrics create doubt about cash quality and repeatability. Even with positive cash generation in 2025, inconsistent FCF and missing coverage ratios impair confidence in debt coverage, capex funding and dividend sustainability long-term.
Earnings VolatilityHistorical margin swings and an earlier revenue decline point to operational sensitivity to demand or cost shifts. This volatility complicates forecasting, increases execution risk for growth plans and may pressure margins and cash flow during cyclical or structural headwinds.
Beauty Farm Medical & Health Industry, Inc. News
2373 FAQ
What was Beauty Farm Medical & Health Industry, Inc.’s price range in the past 12 months?
Beauty Farm Medical & Health Industry, Inc. lowest stock price was HK$16.30 and its highest was HK$41.60 in the past 12 months.
What is Beauty Farm Medical & Health Industry, Inc.’s market cap?
Beauty Farm Medical & Health Industry, Inc.’s market cap is HK$4.60B.
When is Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date?
Beauty Farm Medical & Health Industry, Inc.’s upcoming earnings report date is Sep 01, 2026 which is in 80 days.
How were Beauty Farm Medical & Health Industry, Inc.’s earnings last quarter?
Beauty Farm Medical & Health Industry, Inc. released its earnings results on Mar 27, 2026. The company reported HK$0.752 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.752.
Is Beauty Farm Medical & Health Industry, Inc. overvalued?
According to Wall Street analysts Beauty Farm Medical & Health Industry, Inc.’s price is currently Undervalued.
Does Beauty Farm Medical & Health Industry, Inc. pay dividends?
Beauty Farm Medical & Health Industry, Inc. pays a Annually dividend of HK$0.72 which represents an annual dividend yield of 1.97%. See more information on Beauty Farm Medical & Health Industry, Inc. dividends here
What is Beauty Farm Medical & Health Industry, Inc.’s EPS estimate?
Beauty Farm Medical & Health Industry, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beauty Farm Medical & Health Industry, Inc. have?
Beauty Farm Medical & Health Industry, Inc. has 251,593,720 shares outstanding.
What happened to Beauty Farm Medical & Health Industry, Inc.’s price movement after its last earnings report?
Beauty Farm Medical & Health Industry, Inc. reported an EPS of HK$0.752 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.147%.
Which hedge fund is a major shareholder of Beauty Farm Medical & Health Industry, Inc.?
Currently, no hedge funds are holding shares in HK:2373
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beauty Farm Medical & Health Industry, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.26%
12-Months-Change
Fundamentals
Return on Equity
33.37%
Trailing 12-Months
Asset Growth
23.50%
Trailing 12-Months
Company Description
Beauty Farm Medical & Health Industry, Inc.
Beauty Farm Medical and Health Industry Inc., established in 1993 and based in Shanghai, People's Republic of China, delivers comprehensive beauty and health management services across China. Its diverse offerings encompass traditional beauty treatments; advanced aesthetic medical services, including non-surgical options like energy-based therapies and injections, as well as surgical procedures; and specialized subhealth assessment and intervention programs. As of June 30, 2022, the company operated a network of 352 stores under its BeautyFarm, Palaispa, Neology, and CellCare brands, with 177 being directly owned and 175 franchised.
2373 Stock 12 Month Forecast
Average Price Target
HK$31.31
▲(18.79% Upside)
Technical Analysis
Raily Aesthetic Medicine International Holdings Limited
―
Town Health International Medical Group Ltd.
―
Hygeia Healthcare Holdings Co., Ltd.
―
Arrail Group Ltd.
―
UMP Healthcare Holdings Limited
―
Options Prices
Currently, No data available
---